Literature DB >> 20233479

Comment on screening by MRI mentioned in the reviews by narod and møller.

Mieke Kriege1, Cecile Tm Brekelmans, Jan Gm Klijn.   

Abstract

Entities:  

Year:  2004        PMID： 20233479      PMCID： PMC2839989          DOI： 10.1186/1897-4287-2-1-17

Source DB:  PubMed          Journal:  Hered Cancer Clin Pract        ISSN： 1731-2302            Impact factor:   2.857


× No keyword cloud information.
  8 in total

1.  Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group.

Authors:  J Brown; D Buckley; A Coulthard; A K Dixon; J M Dixon; D F Easton; R A Eeles; D G Evans; F G Gilbert; M Graves; C Hayes; J P Jenkins; A P Jones; S F Keevil; M O Leach; G P Liney; S M Moss; A R Padhani; G J Parker; L J Pointon; B A Ponder; T W Redpath; J P Sloane; L W Turnbull; L G Walker; R M Warren
Journal:  Magn Reson Imaging       Date:  2000-09       Impact factor: 2.546

2.  Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

Authors:  M J Stoutjesdijk; C Boetes; G J Jager; L Beex; P Bult; J H Hendriks; R J Laheij; L Massuger; L E van Die; T Wobbes; J O Barentsz
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

3.  Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer.

Authors:  E Warner; D B Plewes; R S Shumak; G C Catzavelos; L S Di Prospero; M J Yaffe; V Goel; E Ramsay; P L Chart; D E Cole; G A Taylor; M Cutrara; T H Samuels; J P Murphy; J M Murphy; S A Narod
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

4.  Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk.

Authors:  C T Brekelmans; C Seynaeve; C C Bartels; M M Tilanus-Linthorst; E J Meijers-Heijboer; C M Crepin; A A van Geel; M Menke; L C Verhoog; A van den Ouweland; I M Obdeijn; J G Klijn
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

5.  Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.

Authors:  E J Meijers-Heijboer; L C Verhoog; C T Brekelmans; C Seynaeve; M M Tilanus-Linthorst; A Wagner; L Dukel; P Devilee; A M van den Ouweland; A N van Geel; J G Klijn
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

6.  Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

Authors:  C K Kuhl; R K Schmutzler; C C Leutner; A Kempe; E Wardelmann; A Hocke; M Maringa; U Pfeifer; D Krebs; H H Schild
Journal:  Radiology       Date:  2000-04       Impact factor: 11.105

7.  Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Authors:  Lauren Scheuer; Noah Kauff; Mark Robson; Bridget Kelly; Richard Barakat; Jaya Satagopan; Nathan Ellis; Martee Hensley; Jeff Boyd; Patrick Borgen; Larry Norton; Kenneth Offit
Journal:  J Clin Oncol       Date:  2002-03-01       Impact factor: 44.544

8.  MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC).

Authors:  M Kriege; C T Brekelmans; C Boetes; E J Rutgers; J C Oosterwijk; R A Tollenaar; R A Manoliu; R Holland; H J de Koning; J G Klijn
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.